We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Cayman Valinomycin
List Price $168.00 Your Price $168.00
Cayman Valinomycin - CAYM (Additional S&H Or Hazmat Fees May Apply)
NETA PART: CAYM-10009152-50
MFG.PART: 10009152-50
UNSPSC: 12352200
Manufacturer: Cayman


Product Description
Valinomycin is a cyclododecadepsipeptide potassium-
WARNING This product is not for human or veterinary use.
Technical Information
Formal Name
3,6,9,15,18,21,27,30,33- nonaisopropyl- 12,24,36- trimethyl- 1,7,13,19,25,31- hexaoxa- 4,10,16,22,28,34- hexaaza- cyclohexatriacontane- 2,5,8,11,14,17,20,23,26,29,32,35- dodecaone
CAS Number
2001-95-8
Synonyms
- NSC 122023
Molecular Formula
C54H90N6O18
Formula Weight
1111.3
Purity
≥95%
Formulation(Request formulation change)
A crystalline solid
Solubility(Learn about Variance in Solubility)
- DMF: 30 mg/mL
- DMSO: 5 mg/mL
- Ethanol: 10 mg/mL
SMILES
CC(C)[C@H]1OC(=O)C(NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)[C@H](OC(=O)[C@@H](NC(=O)C(C)OC(=O)[C@H](NC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
InChi Code
InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/
InChi Key
FCFNRCROJUBPLU-CVZFCLRKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room Temperature in continental US; may vary elsewhere
Stability
≥ 4 years
| SKU | CAYM-10009152-50 |
|---|---|
| Supplier Part Number | 10009152-50 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Y |
| CountryOfOrigin | United States |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | Y |
| CAS Number | 2001-95-8 |
| Energy Star | No |
| Green | No |
| Controlled | N |

